Loss of PDZK1 causes coronary artery occlusion and myocardial infarction in Paigen diet-fed apolipoprotein E deficient mice
- PMID: 19956623
- PMCID: PMC2779610
- DOI: 10.1371/journal.pone.0008103
Loss of PDZK1 causes coronary artery occlusion and myocardial infarction in Paigen diet-fed apolipoprotein E deficient mice
Abstract
Background: PDZK1 is a four PDZ-domain containing protein that binds to the carboxy terminus of the HDL receptor, scavenger receptor class B type I (SR-BI), and regulates its expression, localization and function in a tissue-specific manner. PDZK1 knockout (KO) mice are characterized by a marked reduction of SR-BI protein expression ( approximately 95%) in the liver (lesser or no reduction in other organs) with a concomitant 1.7 fold increase in plasma cholesterol. PDZK1 has been shown to be atheroprotective using the high fat/high cholesterol ('Western') diet-fed murine apolipoprotein E (apoE) KO model of atherosclerosis, presumably because of its role in promoting reverse cholesterol transport via SR-BI.
Principal findings: Here, we have examined the effects of PDZK1 deficiency in apoE KO mice fed with the atherogenic 'Paigen' diet for three months. Relative to apoE KO, PDZK1/apoE double KO (dKO) mice showed increased plasma lipids (33% increase in total cholesterol; 49 % increase in unesterified cholesterol; and 36% increase in phospholipids) and a 26% increase in aortic root lesions. Compared to apoE KO, dKO mice exhibited substantial occlusive coronary artery disease: 375% increase in severe occlusions. Myocardial infarctions, not observed in apoE KO mice (although occasional minimal fibrosis was noted), were seen in 7 of 8 dKO mice, resulting in 12 times greater area of fibrosis in dKO cardiac muscle.
Conclusions: These results show that Paigen-diet fed PDZK1/apoE dKO mice represent a new animal model useful for studying coronary heart disease and suggest that PDZK1 may represent a valuable target for therapeutic intervention.
Conflict of interest statement
Figures




Similar articles
-
Influence of PDZK1 on lipoprotein metabolism and atherosclerosis.Biochim Biophys Acta. 2008 May;1782(5):310-6. doi: 10.1016/j.bbadis.2008.02.004. Epub 2008 Mar 10. Biochim Biophys Acta. 2008. PMID: 18342019 Free PMC article.
-
Loss of SR-BI expression leads to the early onset of occlusive atherosclerotic coronary artery disease, spontaneous myocardial infarctions, severe cardiac dysfunction, and premature death in apolipoprotein E-deficient mice.Circ Res. 2002 Feb 22;90(3):270-6. doi: 10.1161/hh0302.104462. Circ Res. 2002. PMID: 11861414
-
Targeted disruption of the PDZK1 gene in mice causes tissue-specific depletion of the high density lipoprotein receptor scavenger receptor class B type I and altered lipoprotein metabolism.J Biol Chem. 2003 Dec 26;278(52):52820-5. doi: 10.1074/jbc.M310482200. Epub 2003 Oct 8. J Biol Chem. 2003. PMID: 14551195
-
Role of the adaptor protein PDZK1 in controlling the HDL receptor SR-BI.Curr Opin Lipidol. 2009 Jun;20(3):236-41. doi: 10.1097/MOL.0b013e32832aee82. Curr Opin Lipidol. 2009. PMID: 19421056 Free PMC article. Review.
-
Myocardial infarction following atherosclerosis in murine models.Curr Drug Targets. 2008 Mar;9(3):217-23. doi: 10.2174/138945008783755566. Curr Drug Targets. 2008. PMID: 18336240 Review.
Cited by
-
Establishment of a novel murine model of ischemic cardiomyopathy with multiple diffuse coronary lesions.PLoS One. 2013 Aug 12;8(8):e70755. doi: 10.1371/journal.pone.0070755. eCollection 2013. PLoS One. 2013. PMID: 23950999 Free PMC article.
-
Establishment of a rat model with diet-induced coronary atherosclerosis.J Biomed Res. 2016 Oct 17;31(1):47-55. doi: 10.7555/JBR.31.20160020. J Biomed Res. 2016. PMID: 28808185 Free PMC article.
-
Transcriptomic research in atherosclerosis: Unravelling plaque phenotype and overcoming methodological challenges.J Mol Cell Cardiol Plus. 2023 Sep 12;6:100048. doi: 10.1016/j.jmccpl.2023.100048. eCollection 2023 Dec. J Mol Cell Cardiol Plus. 2023. PMID: 39802625 Free PMC article. Review.
-
Identification of the PDZ3 domain of the adaptor protein PDZK1 as a second, physiologically functional binding site for the C terminus of the high density lipoprotein receptor scavenger receptor class B type I.J Biol Chem. 2011 Jul 15;286(28):25171-86. doi: 10.1074/jbc.M111.242362. Epub 2011 May 23. J Biol Chem. 2011. PMID: 21602281 Free PMC article.
-
Coronary Microvascular Dysfunction is Associated with Augmented Lysosomal Signaling in Hypercholesterolemic Mice.bioRxiv [Preprint]. 2024 Jul 12:2024.07.10.603000. doi: 10.1101/2024.07.10.603000. bioRxiv. 2024. Update in: J Am Heart Assoc. 2024 Dec 3;13(23):e037460. doi: 10.1161/JAHA.124.037460. PMID: 39026774 Free PMC article. Updated. Preprint.
References
-
- Kumar V, Abbas A, Fausto N. Elsevier and Saunders; 2005. Robbin's and Cotran pathologic basis of disease. pp. 516–525.
-
- Chase A, Jackson C, Angelini G, Suleiman M. Coronary artery disease progression is associated with increased resistance of hearts and myocytes to cardiac insults. Crit Care Med. 2007;35:2344–2351. - PubMed
-
- Zhang S, Reddick R, Piedrahita J, Maeda N. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science. 1992;258:468–471. - PubMed
-
- Nakashima Y, Plump A, Raines E, Breslow J, Ross R. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb. 1994;14:133–140. - PubMed
-
- Plump A, Smith J, Hayek T, Aalto-Setala K, Walsh A, et al. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell. 1992;71:343–353. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous